Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
| Status: | Recruiting |
|---|---|
| Conditions: | Brain Cancer, Lymphoma |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 5/27/2013 |
| Start Date: | April 2009 |
| Contact: | Victoria M Divino, BA |
| Email: | victoria.divino@oxfordoutcomes.com |
| Phone: | 240-482-0034 |
Content Validation of the EORTC QLQ-C30 Version 3.0, and NIH Quality of Life and Symptoms Questionnaire for Pheochromocytoma and Paraganglioma
The purpose of this qualitative study is to evaluate the clarity and comprehensiveness of
two disease-specific questionnaires, and to evaluate how effective these questionnaires are
at assessing the quality of life and symptoms of patients with pheochromocytoma or
paraganglioma.
Inclusion Criteria:
- Provide written informed consent and be willing to comply with protocol requirements
- Participant is aged ≥ 18
- Have a documented (medical record) diagnosis of either pheochromocytoma or
paraganglioma with active symptoms or within 60 days of curative therapy
Exclusion Criteria:
Patient is currently asymptomatic from pheochromocytoma/paraganglioma diagnosis or
duration > 60 days from curative therapy
- Participant has a clinically significant disorder, including alcohol or drug abuse,
which may interfere with study participation or which may affect the outcome of the
study as judged by the investigator.
- Participant has a mental disability or significant mental illness, legal incapacity
or limited legal capacity or any other lack of fitness, in the investigator's
opinion, to preclude the subject's participation in or ability to complete the study.
- Participant is currently too unwell to take part in the study.
We found this trial at
1
site
Click here to add this to my saved trials
